BACKGROUND Passive immunotherapy with convalescent plasma (CP) is a potential
treatment for COVID-19. Evidence from controlled clinical trials is inconclusive. METHODS We …

Background Passive immunotherapy with convalescent plasma (CP) is a potential treatment
for COVID-19 for which evidence from controlled clinical trials is lacking. Methods We …

One or more of the authors of this paper have disclosed potential or pertinent conflicts of
interest, which may include receipt of payment, either direct or indirect, institutional support, or …

The aim of our study was to elucidate if SARS-CoV-2 viral load on admission, measured by
real-time reverse transcriptase–polymerase chain reaction (rRT-PCR) cycle threshold (Ct) …

Objective Patients with coronavirus disease 2019 (COVID‐19) present coagulation
abnormalities and thromboembolic events that resemble antiphospholipid syndrome (APS). This …

We have investigated the evolution of the neutralizing response against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) variants at 8 months after Pfizer-BNT162b2 …

We have measured the humoral response to messenger RNA (mRNA) vaccines in COVID‐19
naïve and convalescent individuals. Third doses of mRNA COVID‐19 vaccines induced a …

Few studies have assessed the clinical and bacterial characteristics of Pseudomonas aeruginosa
(PA) bacteraemic pneumonia (BP) episodes. This study analysed all non-duplicate PA-…

Background Staphylococcus aureus is the leading cause of prosthetic joint infection (PJI).
Beyond the antibiogram, little attention has been paid to the influence of deep microbiological …

The emergence of ceftazidime/avibactam (CZA) resistance among Guiana extended-spectrum
β-lactamase (GES)-producing Pseudomonas aeruginosa isolates has rarely been …